HEADER TRANSFERASE 08-SEP-06 2J50 TITLE STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-739358 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 6; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 126-403; COMPND 5 SYNONYM: SERINE/THREONINE KINASE 15, AURORA/IPL1-RELATED KINASE 1, COMPND 6 AURORA-RELATED KINASE 1, HARK1, AURORA-A, BREAST-TUMOR-AMPLIFIED COMPND 7 KINASE; COMPND 8 EC: 2.7.11.1; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: USING MASS SPECTROMETRY THE PROTEIN WAS SEEN TO BE COMPND 11 PARTIALLY PHOSPHORYLATED BUT NO PHOSPHATES WERE SEEN IN THE STRUCTURE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, PHOSPHORYLATION, NUCLEOTIDE-BINDING, KINASE, CELL CYCLE, KEYWDS 2 ATP-BINDING, NUCLEOTIDE- BINDING, SERINE/THREONINE-PROTEIN KINASE, KEYWDS 3 SERINE-THREONINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR A.D.CAMERON,G.IZZO,P.STORICI,L.RUSCONI,D.FANCELLI,M.VARASI,D.BERTA, AUTHOR 2 S.BINDI,B.FORTE,D.SEVERINO,R.TONANI,P.VIANELLO REVDAT 6 08-MAY-24 2J50 1 REMARK REVDAT 5 03-APR-19 2J50 1 SOURCE REVDAT 4 29-JUL-15 2J50 1 REMARK VERSN HETSYN FORMUL REVDAT 3 24-FEB-09 2J50 1 VERSN REVDAT 2 30-NOV-06 2J50 1 JRNL REVDAT 1 06-NOV-06 2J50 0 JRNL AUTH D.FANCELLI,J.MOLL,M.VARASI,R.BRAVO,R.ARTICO,D.BERTA,S.BINDI, JRNL AUTH 2 A.D.CAMERON,I.CANDIANI,P.CAPPELLA,P.CARPINELLI,W.CROCI, JRNL AUTH 3 B.FORTE,M.L.GIORGINI,J.KLAPWIJK,A.MARSIGLIO,E.PESENTI, JRNL AUTH 4 M.ROCCHETTI,F.ROLETTO,D.SEVERINO,C.SONCINI,P.STORICI, JRNL AUTH 5 R.TONANI,P.ZUGNONI,P.VIANELLO JRNL TITL 1,4,5,6-TETRAHYDROPYRROLO[3,4-C]PYRAZOLES: IDENTIFICATION OF JRNL TITL 2 A POTENT AURORA KINASE INHIBITOR WITH A FAVORABLE ANTITUMOR JRNL TITL 3 KINASE INHIBITION PROFILE. JRNL REF J.MED.CHEM. V. 49 7247 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 17125279 JRNL DOI 10.1021/JM060897W REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 11862 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 609 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3770 REMARK 3 BIN FREE R VALUE : 0.4280 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.043 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4084 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 95.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.35000 REMARK 3 B22 (A**2) : 2.03000 REMARK 3 B33 (A**2) : 4.32000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM SIGMAA (A) : 0.53 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.50 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.67 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.990 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : GROUP REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 52.25 REMARK 3 REMARK 3 NCS MODEL : CONSTR REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : 358.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED BY ANALOGY WITH REMARK 3 A HIGHER RESOLUTION STRUCTURE THE SPACE GROUP WAS DEFINED AS REMARK 3 P212121, HOWEVER THE SPACE GROUP SEEMS TO BE P41212. IN THE REMARK 3 HIGHER RESOLUTION STRUCTURE THE SYMMETRY BROKE DOWN AT HIGHER REMARK 3 RESOLUTION. THE STRUCTURE WAS REFINED WITH STRICT NCS. REMARK 4 REMARK 4 2J50 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-SEP-06. REMARK 100 THE DEPOSITION ID IS D_1290029931. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93 REMARK 200 MONOCHROMATOR : DIAMOND (111), GE(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11903 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.71000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 2J4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 2000MME, 0.2M LITHIUM REMARK 280 SULPHATE, 0.1M SODIUM ACETATE PH 4.6, 2% ISOPROPANOL, 2MM DTT, REMARK 280 PH 4.60 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 37.84400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.41450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.39100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.41450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.84400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.39100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 124 REMARK 465 PRO A 125 REMARK 465 ARG A 126 REMARK 465 GLN A 127 REMARK 465 HIS A 280 REMARK 465 ALA A 281 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 SER A 284 REMARK 465 ARG A 285 REMARK 465 ARG A 286 REMARK 465 THR A 287 REMARK 465 GLY A 303 REMARK 465 ARG A 304 REMARK 465 MET A 305 REMARK 465 HIS A 306 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 465 ASN A 392 REMARK 465 CYS A 393 REMARK 465 GLN A 394 REMARK 465 ASN A 395 REMARK 465 LYS A 396 REMARK 465 GLU A 397 REMARK 465 SER A 398 REMARK 465 ALA A 399 REMARK 465 SER A 400 REMARK 465 LYS A 401 REMARK 465 GLN A 402 REMARK 465 SER A 403 REMARK 465 GLY B 124 REMARK 465 PRO B 125 REMARK 465 ARG B 126 REMARK 465 GLN B 127 REMARK 465 HIS B 280 REMARK 465 ALA B 281 REMARK 465 PRO B 282 REMARK 465 SER B 283 REMARK 465 SER B 284 REMARK 465 ARG B 285 REMARK 465 ARG B 286 REMARK 465 THR B 287 REMARK 465 GLY B 303 REMARK 465 ARG B 304 REMARK 465 MET B 305 REMARK 465 HIS B 306 REMARK 465 PRO B 390 REMARK 465 SER B 391 REMARK 465 ASN B 392 REMARK 465 CYS B 393 REMARK 465 GLN B 394 REMARK 465 ASN B 395 REMARK 465 LYS B 396 REMARK 465 GLU B 397 REMARK 465 SER B 398 REMARK 465 ALA B 399 REMARK 465 SER B 400 REMARK 465 LYS B 401 REMARK 465 GLN B 402 REMARK 465 SER B 403 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 279 CG1 CG2 REMARK 470 LYS A 389 CA C O CB CG CD CE REMARK 470 LYS A 389 NZ REMARK 470 VAL B 279 CG1 CG2 REMARK 470 LYS B 389 CA C O CB CG CD CE REMARK 470 LYS B 389 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLN A 223 OE1 GLN B 223 1455 1.76 REMARK 500 O LYS A 224 NE2 GLN B 370 3655 1.98 REMARK 500 NE2 GLN A 370 O LYS B 224 2664 1.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 159 -174.33 -175.81 REMARK 500 ILE A 184 -73.35 -60.85 REMARK 500 GLN A 185 -18.62 -42.41 REMARK 500 ASP A 202 -153.06 -156.13 REMARK 500 ALA A 203 -82.83 -43.16 REMARK 500 LYS A 224 -60.81 -98.96 REMARK 500 SER A 226 -46.93 61.06 REMARK 500 GLU A 230 -37.69 -35.80 REMARK 500 ARG A 255 -145.81 -81.99 REMARK 500 LEU A 289 128.76 67.13 REMARK 500 ILE A 301 -17.77 -142.83 REMARK 500 GLU A 308 23.07 -45.54 REMARK 500 ALA A 331 -162.72 -126.28 REMARK 500 ASP A 350 -56.72 -28.39 REMARK 500 THR A 353 152.85 -43.70 REMARK 500 LEU A 364 49.98 -78.11 REMARK 500 SER A 387 -154.93 -82.01 REMARK 500 SER A 388 167.44 176.44 REMARK 500 LEU B 159 -174.37 -175.81 REMARK 500 ILE B 184 -73.34 -60.83 REMARK 500 GLN B 185 -18.69 -42.39 REMARK 500 ASP B 202 -153.07 -156.11 REMARK 500 ALA B 203 -82.83 -43.18 REMARK 500 LYS B 224 -60.75 -98.95 REMARK 500 SER B 226 -46.96 61.07 REMARK 500 GLU B 230 -37.79 -35.73 REMARK 500 ARG B 255 -145.78 -82.01 REMARK 500 LEU B 289 128.73 67.19 REMARK 500 ILE B 301 -17.74 -142.84 REMARK 500 GLU B 308 23.04 -45.52 REMARK 500 ALA B 331 -162.71 -126.28 REMARK 500 ASP B 350 -56.72 -28.37 REMARK 500 THR B 353 152.83 -43.68 REMARK 500 LEU B 364 50.00 -78.13 REMARK 500 SER B 387 -154.92 -82.04 REMARK 500 SER B 388 167.47 176.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1391 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1391 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 627 A 1390 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 627 B 1390 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MQ4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE REMARK 900 RELATED ID: 1MUO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE REMARK 900 RELATED ID: 1OL5 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-A 122-403, PHOSPHORYLATED ON THR287, THR288 AND REMARK 900 BOUND TO TPX2 1-43 REMARK 900 RELATED ID: 1OL6 RELATED DB: PDB REMARK 900 STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF AURORA-A REMARK 900 RELATED ID: 1OL7 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287, THR288 REMARK 900 RELATED ID: 2BMC RELATED DB: PDB REMARK 900 AURORA-2 T287D T288D COMPLEXED WITH PHA- 680632 REMARK 900 RELATED ID: 2C6D RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH ADPNP REMARK 900 RELATED ID: 2C6E RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH A 5- REMARK 900 AMINOPYRIMIDINYL QUINAZOLINE INHIBITOR REMARK 900 RELATED ID: 2J4Z RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA -680626 REMARK 999 REMARK 999 SEQUENCE REMARK 999 GP IS PRESENT AT START DUE TO CLONING ARTIFACT DBREF 2J50 A 124 125 PDB 2J50 2J50 124 125 DBREF 2J50 A 126 403 UNP O14965 STK6_HUMAN 126 403 DBREF 2J50 B 124 125 PDB 2J50 2J50 124 125 DBREF 2J50 B 126 403 UNP O14965 STK6_HUMAN 126 403 SEQRES 1 A 280 GLY PRO ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY SEQRES 2 A 280 ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU SEQRES 3 A 280 ALA ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS SEQRES 4 A 280 VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU SEQRES 5 A 280 HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU SEQRES 6 A 280 ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS SEQRES 7 A 280 ASP ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO SEQRES 8 A 280 LEU GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS SEQRES 9 A 280 PHE ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU SEQRES 10 A 280 ALA ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE SEQRES 11 A 280 HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER SEQRES 12 A 280 ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL SEQRES 13 A 280 HIS ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR SEQRES 14 A 280 LEU ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET SEQRES 15 A 280 HIS ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU SEQRES 16 A 280 CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA SEQRES 17 A 280 ASN THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL SEQRES 18 A 280 GLU PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG SEQRES 19 A 280 ASP LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN SEQRES 20 A 280 ARG PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE SEQRES 21 A 280 THR ALA ASN SER SER LYS PRO SER ASN CYS GLN ASN LYS SEQRES 22 A 280 GLU SER ALA SER LYS GLN SER SEQRES 1 B 280 GLY PRO ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY SEQRES 2 B 280 ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU SEQRES 3 B 280 ALA ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS SEQRES 4 B 280 VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU SEQRES 5 B 280 HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU SEQRES 6 B 280 ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS SEQRES 7 B 280 ASP ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO SEQRES 8 B 280 LEU GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS SEQRES 9 B 280 PHE ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU SEQRES 10 B 280 ALA ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE SEQRES 11 B 280 HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER SEQRES 12 B 280 ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL SEQRES 13 B 280 HIS ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR SEQRES 14 B 280 LEU ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET SEQRES 15 B 280 HIS ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU SEQRES 16 B 280 CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA SEQRES 17 B 280 ASN THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL SEQRES 18 B 280 GLU PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG SEQRES 19 B 280 ASP LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN SEQRES 20 B 280 ARG PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE SEQRES 21 B 280 THR ALA ASN SER SER LYS PRO SER ASN CYS GLN ASN LYS SEQRES 22 B 280 GLU SER ALA SER LYS GLN SER HET 627 A1390 35 HET SO4 A1391 5 HET 627 B1390 35 HET SO4 B1391 5 HETNAM 627 N-[(3E)-5-[(2R)-2-METHOXY-2-PHENYLACETYL]PYRROLO[3,4- HETNAM 2 627 C]PYRAZOL-3(5H)-YLIDENE]-4-(4-METHYLPIPERAZIN-1-YL) HETNAM 3 627 BENZAMIDE HETNAM SO4 SULFATE ION HETSYN 627 DANUSERTIB; PHA-739358 FORMUL 3 627 2(C26 H30 N6 O3) FORMUL 4 SO4 2(O4 S 2-) HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 ALA A 172 1 7 HELIX 3 3 HIS A 176 SER A 186 1 11 HELIX 4 4 VAL A 218 SER A 226 1 9 HELIX 5 5 ASP A 229 SER A 249 1 21 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 THR A 292 LEU A 296 5 5 HELIX 8 8 PRO A 297 ILE A 301 5 5 HELIX 9 9 LYS A 309 GLY A 325 1 17 HELIX 10 10 THR A 333 VAL A 344 1 12 HELIX 11 11 THR A 353 LEU A 364 1 12 HELIX 12 12 ASN A 367 ARG A 371 5 5 HELIX 13 13 MET A 373 HIS A 380 1 8 HELIX 14 14 HIS A 380 SER A 387 1 8 HELIX 15 15 ALA B 129 GLU B 131 5 3 HELIX 16 16 LYS B 166 ALA B 172 1 7 HELIX 17 17 HIS B 176 SER B 186 1 11 HELIX 18 18 VAL B 218 SER B 226 1 9 HELIX 19 19 ASP B 229 SER B 249 1 21 HELIX 20 20 LYS B 258 GLU B 260 5 3 HELIX 21 21 THR B 292 LEU B 296 5 5 HELIX 22 22 PRO B 297 ILE B 301 5 5 HELIX 23 23 LYS B 309 GLY B 325 1 17 HELIX 24 24 THR B 333 VAL B 344 1 12 HELIX 25 25 THR B 353 LEU B 364 1 12 HELIX 26 26 ASN B 367 ARG B 371 5 5 HELIX 27 27 MET B 373 HIS B 380 1 8 HELIX 28 28 HIS B 380 SER B 387 1 8 SHEET 1 AA 5 PHE A 133 LYS A 141 0 SHEET 2 AA 5 ASN A 146 GLU A 152 -1 O VAL A 147 N LEU A 139 SHEET 3 AA 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 AA 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 AA 5 LEU A 196 HIS A 201 -1 N TYR A 197 O ILE A 209 SHEET 1 AB 3 GLY A 216 THR A 217 0 SHEET 2 AB 3 LEU A 262 LEU A 264 -1 N LEU A 264 O GLY A 216 SHEET 3 AB 3 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 SHEET 1 AC 2 ILE A 253 HIS A 254 0 SHEET 2 AC 2 TRP A 277 SER A 278 -1 O SER A 278 N ILE A 253 SHEET 1 BA 5 PHE B 133 LYS B 141 0 SHEET 2 BA 5 ASN B 146 GLU B 152 -1 O VAL B 147 N LEU B 139 SHEET 3 BA 5 ILE B 158 PHE B 165 -1 O LEU B 159 N ALA B 150 SHEET 4 BA 5 ARG B 205 LEU B 210 -1 O VAL B 206 N LEU B 164 SHEET 5 BA 5 LEU B 196 HIS B 201 -1 N TYR B 197 O ILE B 209 SHEET 1 BB 3 GLY B 216 THR B 217 0 SHEET 2 BB 3 LEU B 262 LEU B 264 -1 N LEU B 264 O GLY B 216 SHEET 3 BB 3 LEU B 270 ILE B 272 -1 O LYS B 271 N LEU B 263 SHEET 1 BC 2 ILE B 253 HIS B 254 0 SHEET 2 BC 2 TRP B 277 SER B 278 -1 O SER B 278 N ILE B 253 SITE 1 AC1 5 GLY A 142 LYS A 143 PHE A 144 LYS A 162 SITE 2 AC1 5 627 A1390 SITE 1 AC2 5 GLY B 142 LYS B 143 PHE B 144 LYS B 162 SITE 2 AC2 5 627 B1390 SITE 1 AC3 12 ALA A 160 LYS A 162 LEU A 194 GLU A 211 SITE 2 AC3 12 TYR A 212 ALA A 213 PRO A 214 LEU A 215 SITE 3 AC3 12 GLY A 216 GLU A 260 PHE A 275 SO4 A1391 SITE 1 AC4 12 ALA B 160 LYS B 162 LEU B 194 GLU B 211 SITE 2 AC4 12 TYR B 212 ALA B 213 PRO B 214 LEU B 215 SITE 3 AC4 12 GLY B 216 GLU B 260 PHE B 275 SO4 B1391 CRYST1 75.688 86.782 86.829 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013212 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011523 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011517 0.00000